ASND (Ascendis Pharma AS) 3-Year Book Growth Rate : 0.00% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma AS 3-Year Book Growth Rate?

Ascendis Pharma AS's Book Value per Share for the quarter that ended in Sep. 2024 was $-1.81.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Ascendis Pharma AS was 202.20% per year. The lowest was -29.30% per year. And the median was 33.20% per year.

Competitive Comparison of Ascendis Pharma AS's 3-Year Book Growth Rate

For the Biotechnology subindustry, Ascendis Pharma AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's 3-Year Book Growth Rate falls into.

Ascendis Pharma AS 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Ascendis Pharma AS (NAS:ASND) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Ascendis Pharma AS 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.